Candice Willmon
Overview
Explore the profile of Candice Willmon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun C, Willmon C, Wu L, Knopick P, Thoerner J, Vile R, et al.
Front Oncol
. 2016 Jul;
6:166.
PMID: 27458571
Insights from the study of cancer resistance in animals have led to the discovery of novel anticancer pathways and opened new venues for cancer prevention and treatment. Sickle cells (SSRBCs)...
2.
Ilett E, Kottke T, Donnelly O, Thompson J, Willmon C, Diaz R, et al.
Mol Ther
. 2014 Jun;
22(10):1851-63.
PMID: 24957982
Optimum clinical protocols require systemic delivery of oncolytic viruses in the presence of an intact immune system. We show that preconditioning with immune modulators, or loading virus onto carrier cells...
3.
Willmon C, Diaz R, Wongthida P, Galivo F, Kottke T, Thompson J, et al.
Mol Ther
. 2010 Oct;
19(1):140-9.
PMID: 20978474
Despite having potent oncolytic activity, in vitro, direct intratumoral injection of oncolytic vesicular stomatitis virus (VSV) into established AE17ova mesothelioma tumors in C57Bl/6 mice had no therapeutic effect. During studies...
4.
Willmon C, Harrington K, Kottke T, Prestwich R, Melcher A, Vile R
Mol Ther
. 2009 Aug;
17(10):1667-76.
PMID: 19690519
Oncolytic viruses delivered directly into the circulation face many hazards that impede their localization to, and infection of, metastatic tumors. Such barriers to systemic delivery could be overcome if couriers,...
5.
Kottke T, Thompson J, Diaz R, Pulido J, Willmon C, Coffey M, et al.
Clin Cancer Res
. 2009 Jan;
15(2):561-9.
PMID: 19147761
Purpose: The goals of this study were (a) to investigate whether preconditioning of immunocompetent mice with PC-61-mediated regulatory T-cell (Treg) depletion and interleukin-2 (IL-2) would enhance systemic delivery of reovirus...
6.
Kottke T, Diaz R, Kaluza K, Pulido J, Galivo F, Wongthida P, et al.
Mol Ther
. 2008 Oct;
16(12):1910-8.
PMID: 18827807
To protect viral particles from neutralization, sequestration, nonspecific adhesion, and mislocalization following systemic delivery, we have previously exploited the natural tumor-homing properties of antigen-specific CD8+ T cells. Thus, OT-I T...
7.
Qiao J, Kottke T, Willmon C, Galivo F, Wongthida P, Diaz R, et al.
Nat Med
. 2007 Dec;
14(1):37-44.
PMID: 18066076
In many common cancers, dissemination of secondary tumors via the lymph nodes poses the most significant threat to the affected individual. Metastatic cells often reach the lymph nodes by mimicking...